Comparing the current results to its competitors, Pressure Biosciences Inc reported Revenue decrease in the 2 quarter 2024 year on year by -17.59 %, faster than the overall decrease of Pressure Biosciences Inc 's competitors by -1.75 %, recorded in the same quarter.
Pressure Biosciences Inc 's Comment on Competition and Industry Peers
PBI operates in the biomolecule extraction industry, where it competes with companies utilizing various technologies such as mortar and pestle grinding, sonication, rotor-stator homogenization, French Press, bead beating, freezer milling, enzymatic digestion, and chemical dissolution. In the high-pressure technology sector for ultra shear technology (UST), PBI faces competition from Avestin / ATA Scientific (Australia), Bee International (Easton, MA, USA), DyHydromatics (Maynard, MA, USA), ELVEFLOW, an Elvesys brand (Paris, France), GEA Group (Dusseldorf, Germany), and Microfluidics, an IDEX Corp Company (Westwood, MA, USA). These companies represent both direct and indirect competitors to PBI’s UST technology.
Agilent Technologies Inc. operates a business model centered on delivering innovative measurement solutions across industries like life sciences, diagnostics, and chemical analysis. Their revenue primarily comes from sales of instruments, software, and consumables, supplemented by support services. The company emphasizes strong partnerships and collaborations to enhance their market presence and influence.
10x Genomics Inc is a biotechnology company that specializes in providing tools and solutions for genomic research. Their business model revolves around developing innovative technologies and platforms to enable scientists and researchers to gain deeper insights into the structure and function of biological systems. They offer products such as single-cell sequencing and spatial transcriptomics to support various areas of genomics research and accelerate discoveries in fields like cancer research, immunology, and neuroscience.
Sources:
Pressure Biosciences Inc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: publicly traded companies.
For your research, we’ve provided 10 tables on Pressure Biosciences Inc versus competitors, including market share analysis.
You can find them in the navigation menu under Competition.
To download the tables, please subscribe.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.
